Quiescent chicken or quail retina neuroblasts (NR) can be induced to proliferate actively, in culture, by the v-src oncoprotein. The chE2F-1 transcription factor, a physiological partner of the retinoblastoma gene product, is highly expressed in vivo, in dividing chicken neuroretina cells (CNR). It is sharply down-regulated as cells enter the post-mitotic dierentiation stage, thus suggesting that E2F activity is a prerequisite for NR cell proliferation. In the present paper, transient expression assays of dierent forms of chE2F-1 were used to investigate the function of E2F for switching CNR cells from a quiescent to a proliferative state in vitro. Attempts to substitute the eects of v-src by an ectopic expression of E2F-1 were unsuccessful. However, in the same conditions, E2F-1 supports full growth of CEF in serum-depleted medium. Deletion mutants of E2F-1, with potential dominant-negative properties, were transfected in RSV infected CNR cells. One of these truncated mutants induces a G1 phase block in RSV-transformed CNR cells indicating that, although E2F-1 overexpression cannot overcome the cell proliferation block of postmitotic CNR cells E2F-1, activity is an important component of the growth signal pathway delivered by v-src in these nervous cells.
Introduction
Neuroretina is widely used as a model organ to study the developmental strategies of the central nervous system of vertebrates (Adler and Hatlee, 1989; Altshuler et al., 1993; Ben-Dror et al., 1993; Vardimon et al., 1991) . The FGF family of growth factors is required during early stages of morphogenesis (Lillien and Cepko, 1992; Tcheng et al., 1994) and several retinal genes with a potential developmental regulatory function have been characterised (Berko-Flint et al., 1994; Carriere et al., 1993; Gan et al., 1996; Gorovits et al., 1994; Martin et al., 1992; Pierani et al., 1995; Plaza et al., 1995; Pouponnot et al., 1995; Swaroop et al., 1992; Zhou et al., 1996) . Because of the availability of numerous avian oncogenic retroviruses, the avian retina has also provided exquisite conditions to study the eects of oncogenes on the growth regulation of these neural cells which show limited propensity to divide in vitro (Amouyel et al., 1989; Bechade et al., 1985; Calothy et al., 1980; Coll et al., 1988; Crisanti et al., 1995; Dozier et al., 1988) .
The adult neuroretina is composed of several cell types: photoreceptors, neurones and glial cells, all deriving from proliferating neuroectodermal precursors. They enter the post-mitotic and dierentiation stage early during embryogenesis (Adler and Hatlee, 1989; North et al., 1996) . Quail or chicken NR cells dissected from 7 day-old embryos do not grow in culture (Crisanti-Combes et al., 1982) except when infected by retroviruses like the Rous sarcoma virus (RSV). This mitogenic activity is dependent on full src tyrosine kinase activity as shown by the eect of conditional v-src gene mutations (Calothy et al., 1980; Pessac and Calothy, 1974) . Thermosensitive mutant strains of RSV (tsNY68) can be used to revert NR cells to a non-transformed phenotype and to a nonproliferative state at 41.58C, i.e. in non-permissive temperature conditions (Kawai and Hanafusa, 1971) . This property oers a powerful tool for studying genes involved in v-src mediated NR proliferation and it can be used to unravel the mitogenic mechanisms of the vsrc oncoprotein (Gillet et al., 1993) . Because c-src, the cellular homologue of v-src, was shown to be a target of the p34cdc2 kinase at mitosis (Morgan et al., 1989) , it can be assumed that the mitogenic eects of v-src in CNR cells are, like in ®broblasts, mostly mediated in G2/M by sam 68, a mitotic target of src, the precise function of which remains to be determined (Fumagalli et al., 1994; Taylor et al., 1995) . In contrast, G1 synchronous entry of RSV-infected CNR cells following thermal renaturation of v-src (Gillet et al., 1993) are reminiscent of a G1 cell cycle control. Several v-src target genes have been described (Gillet et al., 1993 (Gillet et al., , 1995 Jamal et al., 1994; Li and Drucker, 1994; Michel et al., 1989; Sugano et al., 1987; Yoon and Boettiger, 1994) , but it is dicult to assess which are related to the proliferation or to the oncogenic processes. Moreover, except for c-myc, no gene of the cell cycle machinery has been identi®ed so far as a speci®c v-src regulated gene, although con¯icting reports suggest that the AP1 transcription factor is up-regulated in RSV infected CEF (Wyke et al., 1993 and reviewed in Brown and Cooper, 1996) .
We have previously observed that the chicken transcription factor and cell cycle regulator, E2F-1, is dramatically down-regulated during NR development (Pasteau et al., 1995) and recent studies have shown that this is tightly linked to cell growth arrest (Espanel et al., 1997) . E2F-1 is the best known of the components of the E2F/DP transcription complex, which regulates most of the genes involved in the control of G1/S phase transition (for review, see Cobrinik, 1996; Slansky and Farnham, 1996) . It is believed to play a crucial role in G1 progression as an integrator of growth-promoting and growth-inhibitory signals. Its activity is controlled, in part, through a cell cycle-dependent association with the p105
Rb pocket family of proteins including also its relatives p107 and p130 (Cobrinik et al., 1993; Hiebert et al., 1992; Schwarz et al., 1993; Shirodkar et al., 1992; Zamanian and La Thangue, 1993; Zhu et al., 1993) . Interestingly, deregulation of E2F expression, or diversion of pRb negative control by oncoviral proteins like adenovirus E1A, SV40 large T antigen or human papillomavirus E7 leads in some cases to transformation and acute cell proliferation capacity (La Thangue, 1994; Nevins, 1992; Pasteau et al., 1995; Singh et al., 1994; Yang and Sladek, 1995) . It is thus possible that the deregulation of E2F-1 activity is directly involved in the genesis of neural pathologies, such as retinoblastoma, normally associated with pRb mutations. In the same way, one can imagine that E2F-1, as a physiological partner of pRb, is linked to the proliferation process mediated by v-src in CNR cells.
In view of such a possibility and to estimate the dierent contributions of the G2/M and G1-dependent controls, we have investigated the cell cycle regulatory properties of chE2F-1, in vitro, in NR cell cultures induced to divide by the Rous Sarcoma Virus (RSV). Dierential expression of E2F-1 in proliferating and dierentiating CNR cells in culture was assessed both at the mRNA and protein levels suggesting that E2F activity is a requisite for CNR cell division in vitro. Since transient overexpression of E2F-1 did not result in detectable NR cell proliferation, insight into the cell growth regulatory properties of E2F-1 in CNR was approached conversely by trying to abrogate the mitogenic eect of v-src in these cells. Modi®ed versions of the chE2F-1 genes were constructed and expression was achieved with plasmid expression vectors. Some of these constructs turn out to have dominant negative eects on the proliferation of NIH3T3 immortalised ®broblasts in culture. They also exhibit a profound inhibition on CNR cell proliferation induced by v-src, indicating that E2F-1 is required but is not sucient to drive CNR cells into their cell cycle.
Results

Regulation of E2F activity in dividing or in quiescent chicken neuroretina cells (CNR)
Infection by RSV induces CNR cell proliferation for several generations in vitro. Using a thermosensitive mutant strain of RSV (tsNY68), one can revert cells from a proliferative state, at permissive temperature (378C), to quiescence and to a non-transformed phenotype at 41.58C, i.e. in conditions in which pp60v-src tyrosine kinase activity is severely decreased (Sefton et al., 1980) . To better understand how v-src triggers CNR cell proliferation, we wished to study how major genes involved in cell cycle control responded to this mitogenic stimulus. Focus was given to E2F-1 and pRb partners whose activity appears prominent for the regulation of the G1/S phase transition. Attention was also paid to the study of cdk2 and cdc2 kinases, that control respectively E2F-1 and p105
Rb activity through their interaction and mitosis through speci®c phosphorylation processes (for a review, see Cobrinik, 1996) . Western blot analysis of extracts from exponentially growing CNR cells (lane noted 378C, Figure 1 ) or after division block by inactivation, at 41.58C, of a ts v-src (lanes noted 41.58C, Figure 1) shows a limited decrease of E2F-1, cdc2 and cdk2 protein levels. Only the hypophosphorylated form of p105
Rb , that binds and inactivates members of the E2F family, remains detectable after such a division arrest. It is interesting to note that pp60v-src accumulation is essentially unaected at 41.58C, although its kinase and mitogenic activities are impaired.
In contrast, to the low amplitude eects noted during the transition from division to quiescence, the reverse transition, monitored by a shift from 41.58C to 378C, results in important changes in these cell cycle regulatory proteins. Induction of cell proliferation by reactivation of v-src leads to a dramatic accumulation of cdc2 and cdk2 as well as to a sharp increase of the hyperphosphorylated form of pRb (lanes noted 24 h and 48 h, 378C, Figure 1 ). Although to a lower extent, E2F-1 is also increased at these two time points which, as suggested by earlier work (Gillet et al., 1993) , correspond to a synchronous entrance of cells in S phase (24 h) and in mitosis (48 h). The large increase of cdk2 is of interest since it might contribute to the changes observed in the phosphorylation state of p105
Rb . Altogether, these data suggest that v-src induced CNR proliferation is associated with an upregulation of the cell cycle regulatory proteins.
To get better insight into the mechanism supporting these changes we have analysed the transcript levels of the chE2F transcription factor. Reverse transcriptase 37°C +12h +24h +48h +1h +4h +8h +12h +24h +48h Figure 2 , while levels of the DP1 and DP2 mRNAs are pretty stable, con®rming the conclusion of other studies (Loiseau et al., 1997) , the chE2F-1 message is strongly down-regulated at 41.58C. Conversely, it is sharply induced at 378C, peaking 12 h after the temperature change and after induction of CNR proliferation. This increase occurs earlier (compare results of Figures 1 and 2 for E2F-1) and contrasts with the apparent slight increase of the E2F-1 protein ( Figure 1 ). These dierences were further con®rmed using the more reliable and quantitative RNAse protection assay as shown in Figure 2b . E2F-1 mRNA is dramatically up-regulated following the synchronous re-entry of CNR cells in the cell cycle (compare lanes 2 and 3 of Figure 2b ).
Expression of gag-chE2F-1 fusion proteins allows the proliferation of serum depleted ®broblasts but not of serum stimulated CNR cells
The PTXN3' retroviral vector expressing gag-chE2F-1 or gag-chE2F-1DRb (a E2F-1 mutant lacking the pRb binding domain) fusion proteins was transfected in Chicken Embryo Fibroblasts (CEF). Neomycin resistant cells acquired the capacity to grow in low serum medium (0.5%) and this correlated with the presence of the fusion proteins as indicated by Western blotting (Figure 3a) . Similarly, we have attempted to resume cell quiescence in RSV-free CNR cells by ectopic expression of these mitogenic fusion proteins. CNR cells from 7 day-old embryos were plated and immediately infected with PTXN3' retrovirus particles expressing either the gag-chE2F-1 protein or its deleted C terminal counterpart (chE2F-1DRb). The powerful mitogenic activity of RSV provided a positive control. Cells were Secondary cultures of CEF, infected by viruses with the neo R marker, were selected with G418 for stable expression of exogenous gag-chE2F-1 and gag-chE2F-1DRb fusion proteins. Cells infected by the control retrovirus pTXN3' or by the fusion constructs pTXN3'-chE2F-1 and pTXN3'-chE2F-1DRb, were grown in G-418 supplemented medium (as depicted in the legend). Growth curves were established by plating 5610 4 cells per 35 mm petri dish at day 0; each point corresponds to two petri dishes. Right panel is a Western blot of chE2F-1 fusion proteins (as indicated) expressed in G418 resistant cells. (b) 7 day-old CNR cells were infected by pTXNgag-chE2F-1 and gag-chE2F-1bRb viral supernatants, as indicated, and maintained under G418 selection. Control are cultures infected with the pTXN vector (top left) or the wt SRA strain of RSV (top right). After 3 weeks in culture, CNR cells are labelled with [ observed in cells expressing the gagE2F-1 fusions whereas about 50% of the nuclei of proliferating CNR cells infected by RSV are labelled. CNR growth capacity was also analysed by cell counting, daily over a 7 day-long period, and by BrdU incorporation (not shown). It consistently concluded to absence of growth which is in marked contrast with the results obtained with RSV infected CNR cells. From these experiments we conclude that gagE2F-1 expression is not sucient to sustain CNR proliferation in conditions that allow embryonic ®broblasts to progress in the cell cycle in absence of growth factors.
Biochemical properties of deleted mutants of the ch E2F-1 protein
To get better insight into the mitogenic function of E2F-1 in CNR cells induced to divide by v-src we sought to devise constructs that might disrupt the E2F-1 transcriptional potential. The main functional domains; e.g. binding to DNA, dimerization with the DP proteins and transcriptional activation were independently deleted to generate mutant proteins. These latter forms were expected to bear dominant negative activity when overexpressed in cells. The chE2F-1D(33 ± 175) devoid of the DNA binding domain, chE2F-1D(257 ± 360) lacking part of the transactivation domain and chE2F-1D(192 ± 403) lacking most of the protein except the DNA binding domain (constructs described in Figure 4a) were inserted into the pcDNA3 eucaryotic expression vector containing the strong and ubiquitous pCMV promoter. Correct in vitro engineering and ecient expression of these construct was analysed, as shown in Figure 4b , by coupled in vitro transcription-translation (lanes 1 to 4) and by Western blot of extracts of transfected NIH3T3 cells (lanes 5 to 7). The truncated in vitro labelled proteins have the expected molecular weight indicating that deletion did occur in frame. Western blotting of extracts from transfected cells (lanes 5 to 7) shows that these deleted forms are also expressed in vivo, although to dierent extents (compare lane 7 for the transactivator domain de®cient form to lane 6 for the DNA binding de®cient form). It is worth noting that the mutant chE2F-1D (192 ± 403) could not be detected because the polyclonal antibodies raised against the chicken E2F-1 protein were directed against epitopes contained in the missing region. Thus speci®city and activity of this last E2F-1 version was controlled by gel retardation with a probe containing an E2F site. A GST protein fused to the DNA binding region of chE2F-1 was tested by EMSA and compared to the DNA binding activity of the equivalent complete human (hE2F-1) or chicken (chE2F-1) proteins ( Figure  4c ). The results show that chE2F-1D(192 ± 403) mutant has ecient DNA binding activity suggesting that it is a potential competitor for E2F binding sites when expressed in vivo.
Deletion mutants of chE2F-1 abrogate E2F transcriptional activity in vivo
The rationale for the construction of the mutant deleted forms displayed in Figure 4 is that they should exhibit competitive eects on E2F-1 transcriptional activity if expressed at sucient levels. The DNA binding deleted mutant (D33 ± 175) which retains the DP binding domain is expected to titrate DP proteins while mutants devoid of the transactivation domain (D257 ± 360 and D192 ± 403) should form inactive complexes on the E2F sites of target promoter genes. In order to test this assumption the above constructs were expressed by transient transfection assays of NIH3T3 cells. The CAT reporter gene, driven by the adenovirus E2 promoter, was cotransfected to monitor E2F dependent activity. As reported in Figure 5 , overaccumulation of chE2F-1 (see Figure   4b lane 5) activates the pE2 promoter by a factor 5 to 10 (lane 3). In similar conditions, coexpression of each of the two chicken DP proteins (described in Loiseau et al., 1997) results in a twofold increase of the E2F transcriptional activity (lanes 6 and 7), while DP-1 and DP-2 alone (lanes 4 and 5) do not show similar activity in absence of exogenous E2F-1 (lanes 4 and 5). It is worth noting that none of the three E2F-1 deleted mutants has intrinsic transcriptional activity on the E2 promoter (lanes 8, 14 and 20), even if coexpressed with chDP-1 or chDP-2 (lanes 10 ± 11, 16 ± 17 and 22 ± 23). E2F-dependent transactivation is counteracted in all situations where the three E2F-1 mutants are coexpressed with the normal protein (lanes 9, 15 and 21) and this is independent on the presence of DP proteins (lanes 12 ± 13, 18 ± 19 and 24 ± 25). These eects can be interpreted in terms of a competition between the truncated and the normal proteins for transcriptional complexes sitting on the E2 promoter. Interestingly, the extent of inhibition is dierent among E2F-1 mutants, chE2F-1D(192 ± 403) being the most ecient. These observations are consistent with a E2F negative dominant function of the deleted mutant chE2F-1 forms expressed ectopically in NIH3T3 cells.
Truncated forms of chE2F-1 block proliferation of CNR cells induced to divide by v-src
Inhibition, in vivo, of E2F-mediated transcription prompted us to investigate the function of the various E2F-1 truncated proteins on a normal E2F dependent cell function: the G1/S transition. A ®rst approach Figure 5 Inhibition of E2F-dependent transactivation by chE2F-1 deletion mutants. NIH3T3 cells were transfected with the pOCAT control (lane 1), or with the pE 2 CAT reporter construct (lanes 2 ± 25). The cells were cotransfected with the indicated amount of the following expression vectors for E2F-1 and DP proteins: 1 mg of pcDNA3-chE2F-1 (lanes 3, 6, 7, 9, 12, 13, 15, 18, 19, 21, 24, 25) ; 1 mg of pcDNA3-chDP-1 (lanes 4, 6, 10, 12, 16, 18, 22, 24) ; 1 mg of pcDNA3-chDP-2 (lanes 5, 7 11, 13, 17, 19, 23, 25) ; 1 mg of pcDNA3-chE2F-1D(257 ± 360) (lanes 8 to 13); 1 mg of pcDNA3-chE2F-1D(33 ± 175) (lanes 14 to 19); 1 mg of pcDNA3-chE2F-1D(192 ± 403) (lanes 20 to 25). For each point, CMV promoter vector quantity is constant. CAT activity, measured by Elisa test (Material and methods), has been normalised to X-Gal activity provided a b-gal expression plasmid transfected simultaneously with all the above expression vectors. Values represent average of three separate experiments E2F-1 mediation of v-src mitogenic effects S Pasteau et al consisted in¯ow cytometry (FACS) analysis of the NIH3T3 cell cycle which, as shown above, expressed the dierent E2F-1 mutants at high levels. Because transfection eciency did not exceed 10 ± 30% of the cells (not shown) we had to proceed to selection of the cells that received the transgene. This was achieved by cotransfection, in a 1 to 10 molar ratio, of a vector expressing the CD2 membrane receptor. Fluorescent antibodies against this marker were used to sort the cells CD2 + cells that were thus considered as chE2F-1 expressing cells (note that the chE2F-1 vectors were transfected in tenfold excess as compared to CD2). In contrast, the CD2-cell population is scored as negative for exogenous E2F-1 expression. Transient expression, for 36 h, was followed by measurements of the DNA content in both the CD2(+) and the CD2 (7) population. The results are displayed in Figure 6a . In all experiments, control CD2(7) cell distribution was unmodi®ed, as compared to untransfected control cells (not shown). In addition, it was observed that wt chE2F-1 overexpression had no detectable eect on the distribution of cells in the dierent phases of the cell cycle (top panels of Figure 6a ). In contrast, all the E2F-1 mutants lead to substantial growth arrest as demonstrated by changes in the proportion of CD2(+) cells in S and G2 (right column, Figure 6a ). The extent of the G1 block depends on the type of E2F-1 construct. The mutant retaining only the amino terminus and the DNA binding regions (bottom panels of Figure 6a ) appears as the most ecient since it virtually blocks complete progression of cells in S phase (more than 95% of CD2(+) cells are in G1).
This mutant can be considered as a dominant negative form of the cell cycle E2F-1 functions and it is a potential useful tool to investigate the role of E2F-1 in v-src induced division of CNR cells. Thus, a similar approach as above, was used to analyse, by FACS, the cell cycle distribution of exponentially growing CNR cells infected by RSV. Since we failed the membrane CD2 marker on CNR cell membranes, we selected the transfected cells on the basis of a vector expressing a cytoplasmic protein: the Green Fluorescent Protein (GFP) (Pines, 1995; Ropp et al., 1995; Yeh et al., 1995) . GFP expressing cells were sorted alive prior to processing for cell cycle analysis. As shown in Figure 6b the distribution pattern of CNR in the dierent phases of the cell cycle diers from that of NIH3T3 cells. This re¯ects slower division rates (around 36 h) and a longer lasting G1 period in CNR cells. Expression of the E2F-1 mutants, tested previously in NIH3T3 ®broblasts, gave the following results: chE2F-1D(257 ± 360) exhibited no clear inhibition on cell cycle progression while chE2F-1D(33 ± 175) induced increase of the number of cells in G1 phase from 65 to 75% (not shown). Absence, or low eects of these two constructs, on distribution of GFP + in the cell cycle strongly suggests that GFP, per se, has no eect on the progression of the cells in their division cycle. In agreement with the data obtained in NIH3T3, the chE2F-1D(192 ± 403) version appeared the most eective inhibitor with almost 90% of the CNR cells blocked in G1 (Figure 6b ; GFP + population). Although G1 block in oncogenic transformed CNR occurred at slightly lower extents than in immortalised NIH3T3 cells, the data are qualitatively similar and they lend support to the notion that E2F-1 activity is required as a downstream eector of the v-src mitogenic pathway in these nervous cells.
Discussion
The E2F-1 transcription factor gene is activated in CNR cells induced to divide by v-src
The mechanisms by which the v-src oncoprotein induces proliferation of normally quiescent cells in culture remain to be established (Brickell, 1992) . Although many targets of the kinase activity of the pp60v-src oncoprotein have been identi®ed like the protooncogene products p21ras (Ellis et al., 1990) , raf-1 kinase (Reed et al., 1991) , the AP1 transcription factor (Birchenall-Roberts et al., 1990; Welham et al., 1990) no clear connection with cell cycle control genes and their products has been established so far. C-src, the protooncogenic counterpart of v-src has been identi®ed as a target of the cell cycle mitotic cdc2 kinase but the relevance of this stimulation to cell cycle progression remains unclear (Taylor and Shalloway, 1996) .
In vivo, QNR and CNR cell last divisions stop at E8-9 as a result of the co-ordinate down-regulation of major genes involved in the cell cycle control: p34cdc2, pRb, E2F-1 as well as of cyclin/cdk complexes (North et al., 1996; Espanel et al., 1996) . E2F-1 expression is severely shut-o in post-mitotic neuroretina neurones suggesting that lack of this essential G1/S phase function contributes to the division blocks of these cells (Pasteau et al., 1995) . It was thus tempting to investigate the function of this transcription factor as a mediator of the v-src mitogenic eect in vitro. With a thermosensitive version of the v-src oncoprotein a clear relationship between E2F-1 gene expression and the ability of cells to divide could be observed. However although CNR cell cycle re-entry is followed by a sharp increase in the E2F-1 message, protein changes appear to fall within narrow limits. This could re¯ect the longer life span of the E2F-1 protein as compared to its mRNA. It is also possible that the protein amount needs to be maintained low enough, especially in view of its apoptotic function (reviewed in Slansky and Farnham, 1996) . Finally, post-translational events could amplify minor changes in protein amounts, thereby resulting in transition from quiescence to cell division. One possible clue to the function of E2F proteins in src induced CNR cell division relies on complex formation with p105Rb or related gene products. It is interesting to note that quiescent CNR cells retain only the underphosphorylated form of p105 Rb which inactivates E2F-1 and acts as a repressor of certain growth gene promoters (reviewed in Slansky and Farnham, 1996) . Conversely, cell cycle entry, induced by the reactivation of v-src oncoprotein, is quickly followed by the recovery of a normal pattern of pRb phosphorylated species. This restores the normal and necessary potential for reversible association with E2F-1 during the cell cycle. The above biochemical studies together with the in vivo in situ studies hybridisation during neuroretina development (Pasteau et al., 1995) strongly suggest that the E2F-1/ p105 Rb complex bears an essential control function for neuroretina cell division. 
E2F-1 overexpression cannot replace v-src for induction of proliferation in CNR quiescent cells
In view of the putative function of E2F-1, as a transducer of the v-src mitogenic signal, it was important to test whether simple overexpression of this protein could shunt v-src action. Other work, in REF cells, has shown that E2F-1 prevents cells for entering G0 quiescence upon serum removal (Johnson et al., 1993) and is sucient to stimulate quiescent ®broblasts to enter S phase (Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994) . This question was approached using a retroviral strategy which presents two kinds of advantages: high infection eciency in poorly transfectable neural cells and stable expression from a strong avian retroviral promoter. The PTXN3' retroviral vector allows expression of a fusion protein with a viral gag amino domain, a situation which mimics that found in several naturally occurring mitogenic and transforming viruses (Samarut et al., 1995) . Convincingly, our results have shown that overexpression of gag-chE2F-1 or gag-chE2F-1DRb mutant is sucient, in ®broblasts, to override the negative eects on cell growth, of serum deprivation. Unexpectedly however, expression of these proteins in quiescent CNR cells failed to induce proliferation, indicating that additional components of the cell cycle machinery are altered by src during RSV infection. Similar results were obtained using the replication competent RSV derived RCAS expression vector which contained E2F-1 in place of the v-src gene (Pasteau, unpublished results) . The above results are, at ®rst, intriguing since transformation studies (Pasteau et al., 1995) suggested that constitutive overexpression of E2F-1 could be deleterious for cell survival. It is possible that E2F-1 is toxic only above a threshold level of mitogenic stimuli, a situation clearly dierent from the low serum conditions used here. Moreover, the gag E2F-1 fusion protein might exhibit dierent apoptotic properties than the normal protein. From these data it can be concluded that, although E2F-1 replaces eciently growth factors signals during CEF growth, it cannot substitute to v-src for induction of division in quiescent CNR cells. Thus, it is likely that activation of CNR cell proliferation, by pp60v-src, is a pleiotropic mechanism involving, in addition to E2F-1, many other cellular targets. Some of the latter targets may correspond to other members of the E2F gene family. It might also be that E2F-1 activated expression in infected CNR is not a cause, but just a consequence, of the cell cycle progression triggered by other mitogenic proteins.
Although not sucient, E2F-1 activity is strictly required for v-src-dependent proliferation of CNR cells
To get further insight into the mechanism by which vsrc induces CNR cell proliferation we have sought to compete E2F-1 function at the transcriptional level, on E2F sites of responsive gene promoters. Dierent mutant E2F-1 proteins were developed and, as expected, accumulation of the DNA binding domain of E2F-1 in the cell, resulted in a block of cell proliferation, probably by preventing access of the endogenous E2F factor to E2F responsive promoters. The block is more pronounced in the NIH3T3 mouse immortalised cell line than in v-src transformed CNR. Analogous results are obtained with HeLa cells, another transformed cell line, suggesting that transformation renders the G1 block more dicult. There are several possible explanations to understand this partial failure for CNR proliferation block. Accumulation of the proteins during the transient transfection procedure of neural cells may be lower than in NIH3T3 ®broblasts. Alternatively, in the CNR context, the protein levels need to be higher to abrogate growth signals. We have not been able to test this hypothesis because of a very low transfection yield of CNR cells in culture (around 1%) that makes detection of the protein very dicult. Another hypothesis is that other members of the E2F family (E2F-2 to 5) can substitute more easily for E2F-1 activity or play a more important function in v-src transformed CNR cells than in immortalised ®broblasts. This last assumption will await isolation of the other E2F members in the chick system. Consistent with our ®ndings, but using a dierent approach, inhibition of E2F-1 activity has also been reported to block cell division. For instance, in vivo transfection of a E2F double-stranded DNA decoy inhibits vascular smooth muscle cell proliferation in a model of rat carotid injury (Morishita et al., 1995) . Another strategy, based on the microinjection of a GST-E2F-1 fusion protein containing the DNA binding domain of E2F-1 blocked the induction of the S phase in Balb/c 3T3 cells (Dobrowolski et al., 1994) .
Since the ch E2F-1 mutants, used in this study, rely for their action on dierent steps of E2F-1 activity (competition for binding to E2F sites, trapping of the DP partners, sitting on E2F sites of inactive transactivators) it will be necessary, in the near future, to raise antibodies to characterise such complexes. The ®nding that their respective capacity to compete for E2F-1 activity, in a reporter gene transcription assay, parallels their antiproliferative activity in vivo, suggests that the mechanism is mostly transcriptional. Finally, if these experiments convincingly argue for E2F activity as a positive mediator of Src induced mitogenesis in CNR cells it is likely that clear understanding of these mitogenic mechanisms will also require analysis of src eects on the upstream negative regulators of E2F-p105
Rb function, the socalled cdki inhibitors (Weinberg, 1995) .
Materials and methods
Plasmid construction
The cDNA clones encoding chE2F-1 and the mutant chE2F-1DRb have been previously described (Pasteau et al., 1995) . ChDP-1 and chDP-2 cDNA clones were isolated from a Lambda Zap cDNA library screened with a speci®c chicken cDNA probe generated by RT ± PCR (Loiseau et al., 1997) . The chE2F-1D(257 ± 360) clone was generated by deletion between SmaI sites at nucleotide positions 894 and 1206 of the E2F-1 cDNA. The chE2F-1D(33 ± 175) clone was generated by deletion between SacII sites at positions 222 and 651. The chE2F-1D (192 ± 403) clone was truncated at the C terminus from the PstI site at position 702. These clones were subcloned, in frame, with the ATG codon of the NcoI site of the pSPUTK translation vector E2F-1 mediation of v-src mitogenic effects S Pasteau et al (Stratagene) and in the pcDNA3 eukaryotic expression vector (InVitrogen) that contains the neo R gene. pGEX-chE2F-1 was obtained by subcloning, in frame, a blunted PvuII/NcoI fragment into the SmaI site of pGEX-2T (Pharmacia). This latter plasmid expresses a E2F-1 polypeptide from amino acids (aa) 196 to 346, fused in frame to the glutathione S-transferase (GST) protein.
Cell cultures and transfection procedures
Primary cultures of chicken embryonic ®broblasts (CEF) were prepared from 9 day-old chicken embryos and passaged as previously described (Castellazzi et al., 1990) . Neuroretina cells were prepared from 7 day-old chicken embryos and infected with either the thermosensitive tsNY68 or the SRA wild-type strain of RSV, as previously described (Pessac and Calothy, 1974) . CNR cells were grown and passaged in Eagle basal medium supplemented with 10% foetal calf serum. NIH3T3 cells (ATCC CRL 1658) were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% foetal calf serum.
Transfections were carried out by the standard CaPO 4 precipitation method. Dishes (diameter 10 cm) of cells at 50% con¯uence were transformed with the indicated amount of expression plasmids and carrier DNA. Cells were washed 16 h post-transfection and replenished with fresh medium. They were harvested 24 to 36 h later for FACS analysis or for protein extract preparation. They were further fed with medium supplemented with G418 (250 to 500 mg/ml) to select for stable transformants.
In vitro translation 0.3 to 1 mg of the expression plasmids were transcribed and translated with [ 14 C] leucine in a reticulocyte-coupled TNT transcription-translation lysate (Promega). The conditions were those recommended by the manufacturer.
Preparation of polyclonal antibodies to chE2F-1 Escherichia coli JM109 strain transformed by a plasmid that encoded GST-chE2F-1(196 ± 346) was grown to an absorbency at 600 nm of 0.6 to 0.8, and protein expression was induced with 0.1 mM IPTG (isopropyl-b-D-thiogalactopyranoside, Sigma). Pelleted bacteria were resuspended in 1/50 volume of the culture in NETN (20 mM Tris (pH 8.0), 1 mM EDTA, 0.5% Nonidet P-40 (NP-40) (wt/ vol), 100 mM NaCl) supplemented with inhibitors (200 mM phenylmethylsulfonyl¯uoride, 1 mM dithiothreitol, 1 mg of leupeptin per ml, 1 mg of pepstatin per ml). Lysozyme was added to 0.5 mg/ml, extracts were incubated on ice for 10 min, sonicated three times for 30 s each at a probe setting of 5 and completed with NaCl to a ®nal concentration of 1 M. The lysate was clari®ed by centrifugation at 100 000 g in a Beckman TLA-100 rotor. GST-chE2F-1(196 ± 346) was puri®ed by incubating glutathione beads (Pharmacia) with the extract for 30 min at 48C. After extensive wash with NETN supplemented with inhibitors, puri®ed GST-chE2F-1(196 ± 346) was eluted in 20 mM glutathione in elution buer (200 mM Tris [pH 8.0], 1 mM EDTA, 0.5% NP-40 (wt/vol), 100 mM NaCl). The puri®ed fusion protein used for rabbit immunisation was analysed by SDS ± PAGE.
Antibodies were obtained by an initial injection of a New Zealand White rabbit, with 200 mg, and boosts at month intervals, with 100 mg, of anity-puri®ed . Immunoglobulins were puri®ed by protein A sepharose chromatography.
Immunoblots
Antibodies were from the following sources: chE2F-1 (prepared as described above), pRb from Pharmingen, cdk2 from Santa Cruz Biothechnology Inc, cdc2 was a kind gift of Dr E Nigg (Lausanne and Geneva, Switzerland) and Src was from Oncor Sci.
Whole-cell extracts were prepared from NIH3T3, CEF or CNR cells by standard procedures. Brie¯y, cells were lysed at 5610 6 /0.1 ml in 0.5 M KCl, 35% glycerol, 100 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES, pH 7.4), 5 mM MgCl 2 , 0.5 mM EDTA (pH 8.0), 5 mM NaF, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 1 mM dithiothreitol, 5 mg of aprotinin per ml, 5 mg of leupeptin per ml and then centrifuged at 48C for 45 min at 40 000 g in a TL100 rotor (Beckman) to discard cell debris. Supernatants were removed and protein concentration was determined by the Bradford protein assay reagent (Bio-Rad). 10 mg of cellular protein were separated by sodium dodecyl sulfate-8% polyacrylamide gel electrophoresis (SDS ± PAGE) and transferred to nitrocellulose ®lters (BA-85, Schleicher and SchuÈ ll). The membranes were blocked for 2 h at room temperature in 16TTBS (10 mM Tris-pH 8.0, 150 mM NaCl, 0.05% Tween 20) containing 5% dry milk and then immunoblotted with the indicated antibodies. Horseradish peroxidase-linked sheep anti-mouse immunoglobulin and horseradish peroxidaselinked donkey anti-rabbit immunoglobulin (Amersham) were used as secondary antibodies, and the blots were developed by using the enhanced chemiluminescence system (Amersham).
RNA extraction and RT ± PCR analysis
Total cellular RNA from CNR cell cultures was prepared using the guanidium thiocyanate procedure (Sambrook et al., 1989) . 0.3 mg of total RNA were reverse-transcribed for 45 mn at 378C with 100 units of Moloney murine leukemia virus reverse transcriptase (Gibco-BRL), 250 mM of each dNTP and 5 mM of poly-dT(12 ± 18) primers. A twentieth of these reverse transcriptions were used as templates for PCR ampli®cations on a Perkin Elmer Cetus thermal cycler. PCR reactions were performed using 0.75 mM of the indicated speci®c primers, 250 mM of each dNTP and 2 U Taq DNA polymerase (Appligene) in a ®nal volume of 100 ml. After denaturation at 958C for 5 mn, the 30 cycles of ampli®cation consisted of a denaturation step at 958C for 30 s, an annealing step at 508C for 30 s and a primer extension step at 728C for 40 s.
RNAse protection analysis
RNA was isolated from CEFs in culture as described in the RNA blotting section and analysed using an RNAse protection assay. RNA probes were synthesized from plasmid pBSK/chE2F-1. The plasmid was linearized with ApaI (nt 398 of the cDNA) to provide a template for a 370 nucleotides long labelled riboprobe using T7 RNA polymerase (Riboprobe kit Promega). The riboprobe was puri®ed by denaturing polyacrylamide gel electrophoresis.The ribonuclease protection assay was carried out using the RPA II kit (Ambion) according to the manufacturer instructions. The products were analysed by electrophoresis in 5% Acrylamide/8M urea gels followed by autoradiography.
CAT assays
As indicated, dierent expression plasmids, were cotransfected with a chimeric plasmid containing the CAT reporter gene under the control of the adenovirus E2 promoter. In all instances, 1 mg of a b-Gal expression plasmid was transfected to calibrate for transfection eciency. Assays were performed as described in the CAT Elisa kit protocol provided by Boehringer and bgalactosidase activity was determined from the same extracts with X-Gal.
Flow cytometry and cell cycle analysis
For¯ow cytometry, cells were trypsinized and incubated for 30 min in culture medium at 378C. NIH3T3 cells, after been washed three times in phosphate-buered saline (PBS), were incubated in PBS at a density of 10 6 cells/ 100 ml with anti rat CD2-FITC antibody diluted 50 times. Then, cells were washed three times in PBS and ®xed by addition of three volumes of chilled ethanol (7208C). CNR cells were transfected with 3 mg of an expression vector (Maxygen, AFFYMAX) for the green¯uorescent protein (GFP). They were separated by a BectonDickinson cyto¯uorimeter (FACS-STAR) as a function of GFP-dependent¯uorescence, and ®xed by addition of three volumes of chilled ethanol. The cell suspensions were then stored at 48C. Just prior to FACS analysis, the cells were treated successively by RNAse A (1 mg/ml) and propidium iodide. The analysis was performed on a Becton-Dickinson cyto¯uorimeter (FACS-SCAN) and results analysed with ModFitLT program.
Abbreviations chE2F-1=Chicken E2F-1, hE2F-1=Human E2F-1
